Advertisement
Screener

FORTE BIOSCIENCES, INC. (FBRX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.9 / 5 stars · 16/42 Roast Me

FORTE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

FORTE BIOSCIENCES, INC. (FBRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.29 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12

  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 608.00K shares, a 164.35% increase year-over-year.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 683.90K shares, a 67.59% decline year-over-year.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 115.00K shares.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 125.00K shares.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.58M shares, a 1987.38% increase from fiscal 2024.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 123.60K shares, a 64.17% decline from fiscal 2023.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 345.00K shares, a 71.23% decline from fiscal 2022.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.20M shares, a 111.68% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2026-06-30608.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
1.29M shares
10-Q · filed 2026-08-12
1.41M shares
derived: sum of 3 quarters · filed 2026-08-12
1.53M shares
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31683.90K shares
10-Q · filed 2026-05-11
798.90K shares
derived: sum of 2 quarters · filed 2026-05-11
923.90K shares
derived: sum of 3 quarters · filed 2026-05-11
1.15M shares
derived: sum of 4 quarters · filed 2026-05-11
2025-12-31115.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
240.00K shares
derived: sum of 2 quarters · filed 2026-03-31
470.00K shares
derived: sum of 3 quarters · filed 2026-03-31
2.58M shares
10-K · filed 2026-03-31
2025-09-30125.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
355.00K shares
derived: sum of 2 quarters · filed 2025-11-14
2.46M shares
10-Q · filed 2025-11-14
2.46M shares
derived: sum of 4 quarters · filed 2025-11-14
2025-06-30230.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
2.34M shares
10-Q · filed 2025-08-14
2.34M shares
derived: sum of 3 quarters · filed 2025-08-14
-176.40K shares
derived: sum of 4 quarters · filed 2025-08-14
2025-03-312.11M shares
10-Q · filed 2025-05-15
2.11M shares
derived: sum of 2 quarters · filed 2025-05-15
-406.40K shares
derived: sum of 3 quarters · filed 2025-05-15
-306.40K shares
derived: sum of 4 quarters · filed 2025-05-15
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
-2.52M shares
derived: sum of 2 quarters · filed 2025-03-28
-2.42M shares
derived: sum of 3 quarters · filed 2025-03-28
123.60K shares
10-K · filed 2025-03-28
2024-09-30-2.52M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-2.42M shares
derived: sum of 2 quarters · filed 2024-11-14
123.60K shares
10-Q · filed 2024-11-14
188.60K shares
derived: sum of 4 quarters · filed 2024-11-14
2024-06-30100.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
2.64M shares
10-Q · filed 2024-08-14
2.71M shares
derived: sum of 3 quarters · filed 2024-08-14
2.92M shares
derived: sum of 4 quarters · filed 2024-08-14
2024-03-312.54M shares
10-Q · filed 2024-05-13
2.60M shares
derived: sum of 2 quarters · filed 2024-05-13
2.82M shares
derived: sum of 3 quarters · filed 2024-05-13
2.83M shares
derived: sum of 4 quarters · filed 2024-05-13
2023-12-3165.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
280.00K shares
derived: sum of 2 quarters · filed 2024-03-18
295.00K shares
derived: sum of 3 quarters · filed 2024-03-18
345.00K shares
10-K · filed 2024-03-18
2023-09-30215.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
230.00K shares
derived: sum of 2 quarters · filed 2023-11-13
280.00K shares
10-Q · filed 2023-11-13
330.00K shares
derived: sum of 4 quarters · filed 2023-11-13
2023-06-3015.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
65.00K shares
10-Q · filed 2023-08-14
115.00K shares
derived: sum of 3 quarters · filed 2023-08-14
115.00K shares
derived: sum of 4 quarters · filed 2023-08-14
2023-03-3150.00K shares
10-Q · filed 2023-05-15
100.00K shares
derived: sum of 2 quarters · filed 2023-05-15
100.00K shares
derived: sum of 3 quarters · filed 2023-05-15
554.17K shares
derived: sum of 4 quarters · filed 2023-05-15
2022-12-3150.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
50.00K shares
derived: sum of 2 quarters · filed 2023-03-31
504.17K shares
derived: sum of 3 quarters · filed 2023-03-31
1.20M shares
10-K · filed 2023-03-31
2022-09-300.00 shares
10-Q · filed 2022-11-14
454.17K shares
derived: sum of 2 quarters · filed 2022-11-14
1.15M shares
10-Q · filed 2022-11-14
1.15M shares
derived: sum of 4 quarters · filed 2022-11-14
2022-06-30454.17K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
1.15M shares
10-Q · filed 2022-08-15
1.15M shares
derived: sum of 3 quarters · filed 2022-08-15
1.31M shares
derived: sum of 4 quarters · filed 2022-08-15
2022-03-31695.00K shares
10-Q · filed 2022-05-16
695.00K shares
derived: sum of 2 quarters · filed 2022-05-16
860.00K shares
derived: sum of 3 quarters · filed 2022-05-16
1.18M shares
derived: sum of 4 quarters · filed 2022-05-16
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
165.00K shares
derived: sum of 2 quarters · filed 2022-03-31
482.50K shares
derived: sum of 3 quarters · filed 2022-03-31
566.50K shares
10-K · filed 2022-03-31
2021-09-30165.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
482.50K shares
derived: sum of 2 quarters · filed 2021-11-08
566.50K shares
10-Q · filed 2021-11-08
651.50K shares
derived: sum of 4 quarters · filed 2021-11-08
2021-06-30317.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
401.50K shares
10-Q · filed 2021-08-16
486.50K shares
derived: sum of 3 quarters · filed 2021-08-16
721.50K shares
derived: sum of 4 quarters · filed 2021-08-16
2021-03-3184.00K shares
10-Q · filed 2021-05-10
169.00K shares
derived: sum of 2 quarters · filed 2021-05-10
404.00K shares
derived: sum of 3 quarters · filed 2021-05-10
2020-12-3185.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
320.00K shares
derived: sum of 2 quarters · filed 2021-03-16
655.01K shares
10-K · filed 2021-03-16
2020-09-30235.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
570.01K shares
10-Q · filed 2020-11-09
2020-06-30335.01K shares
10-Q · filed 2020-08-10
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
0.00 shares
derived: sum of 2 quarters · filed 2021-03-16
0.00 shares
10-K · filed 2021-03-16
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
0.00 shares
10-Q · filed 2020-11-09
2019-06-300.00 shares
10-Q · filed 2020-08-10